Loading...
FDA-Approved Oligonucleotide Therapies in 2017
Oligonucleotides (oligos) have been under clinical development for approximately the past 30 years, beginning with antisense oligonucleotides (ASOs) and apatmers and followed about 15 years ago by siRNAs. During that lengthy period of time, numerous clinical trials have been performed and thousands...
Na minha lista:
| Udgivet i: | Mol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417833/ https://ncbi.nlm.nih.gov/pubmed/28366767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.03.023 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|